FAQ

Complement C5a, des-Arginine

Known as: des-Arg, C5a, C5 a, des Arg, C5a, des-Arginine 
A derivative of complement C5a, generated when the carboxy-terminal ARGININE is removed by CARBOXYPEPTIDASE B present in normal human serum. C5a des… (More)

Topic mentions per year

Topic mentions per year

1976-2017
051019762017

Related topics

Related topics

10 relations

Broader (1)

Immunologic Factors
Process of secretionadministration & dosageagonistsantagonists & inhibitors
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Complement C5a, des-Arginine
physiological aspects
agonists
chemical synthesis
Immunologic Factors
standards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
C5L2 is a functional receptor for acylation-stimulating protein.
C5L2 binds acylation-stimulating protein (ASP) with high affinity and is expressed in ASP-responsive cells. Functionality of C5L2… (More)
Is this relevant?
2005
2005
Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
The in vitro activity of DX-619, a new des-F(6)-quinolone, was tested against staphylococci and compared to those of other… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2004
2004
Identification of a region in the vitamin D-binding protein that mediates its C5a chemotactic cofactor function.
The vitamin D-binding protein (DBP), also known as group-specific component or Gc-globulin, is a multifunctional plasma protein… (More)
Is this relevant?
1994
1994
Inactivation of human anaphylatoxin C5a and C5a des-Arg through cleavage by the plasminogen activator activity of a human fibrosarcoma cell line.
The HT-1080 human fibrosarcoma cell line exhibited a plasminogen-dependent ability to inactivate recombinant anaphylatoxin C5a or… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 6
Is this relevant?
1991
1991
Role of granulocytes and C5a in myocardial response to zymosan-activated serum.
Although previous studies have demonstrated that complement (C)5a causes myocardial ischemia and mechanical dysfunction, the… (More)
Is this relevant?
1989
1989
Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
Previous investigation has demonstrated that in vivo complement activation can produce acute lung injury. Complement component… (More)
Is this relevant?
1988
1988
Detection of the terminal complement complex in patient plasma following acute myocardial infarction.
The mechanisms of inflammation responsible for the myocardial tissue damage seen after an acute myocardial infarction (AMI) have… (More)
Is this relevant?
1987
1987
Divergent effects of co-carcinogenic phorbol esters and a synthetic diacylglycerol on human neutrophil chemokinesis and granular enzyme secretion.
The effects of two co-carcinogenic phorbol esters (phorbol myristate acetate (PMA) and phorbol dibutyrate (PDBu] and a synthetic… (More)
Is this relevant?
1986
1986
Inhibition of human neutrophil degranulation by forskolin in the presence of phosphodiesterase inhibitors.
The secretory response of cytochalasin B-treated human polymorphonuclear neutrophils to the peptide chemoattractant f-Met-Leu-Phe… (More)
Is this relevant?
1986
1986
Chemotactic activity for polymorphonuclear and mononuclear leukocytes in rheumatoid synovial fluids.
In order to why polymorphonuclear leukocytes (PMNs) are predominant and mononuclear leukocytes (MNLs) are few in rheumatoid… (More)
Is this relevant?